Voyager Therapeutics
VYGR
VYGR
107 hedge funds and large institutions have $230M invested in Voyager Therapeutics in 2023 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 32 increasing their positions, 30 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
3% less funds holding
Funds holding: 110 → 107 (-3)
13% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 23
Holders
107
Holding in Top 10
–
Calls
$386K
Puts
$200K
Top Buyers
| 1 | +$3.72M | |
| 2 | +$1.63M | |
| 3 | +$1.53M | |
| 4 |
AACP
Advantage Alpha Capital Partners
San Francisco,
California
|
+$1.49M |
| 5 |
BlackRock
New York
|
+$1.41M |
Top Sellers
| 1 | -$2.85M | |
| 2 | -$1.86M | |
| 3 | -$1.86M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.79M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$1.43M |